PortfoliosLab logo
PEN vs. MEDP
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PEN and MEDP is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

PEN vs. MEDP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Penumbra, Inc. (PEN) and Medpace Holdings, Inc. (MEDP). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

PEN:

1.00

MEDP:

-0.51

Sortino Ratio

PEN:

1.52

MEDP:

-0.49

Omega Ratio

PEN:

1.18

MEDP:

0.93

Calmar Ratio

PEN:

0.66

MEDP:

-0.59

Martin Ratio

PEN:

4.54

MEDP:

-0.97

Ulcer Index

PEN:

7.59%

MEDP:

24.11%

Daily Std Dev

PEN:

39.71%

MEDP:

43.74%

Max Drawdown

PEN:

-62.64%

MEDP:

-42.87%

Current Drawdown

PEN:

-18.42%

MEDP:

-33.16%

Fundamentals

Market Cap

PEN:

$10.87B

MEDP:

$8.79B

EPS

PEN:

$1.07

MEDP:

$13.11

PE Ratio

PEN:

262.32

MEDP:

23.32

PEG Ratio

PEN:

-62.27

MEDP:

3.51

PS Ratio

PEN:

8.77

MEDP:

4.07

PB Ratio

PEN:

8.96

MEDP:

14.80

Total Revenue (TTM)

PEN:

$1.24B

MEDP:

$2.16B

Gross Profit (TTM)

PEN:

$787.25M

MEDP:

$672.28M

EBITDA (TTM)

PEN:

$72.64M

MEDP:

$484.51M

Returns By Period

In the year-to-date period, PEN achieves a 18.19% return, which is significantly higher than MEDP's -8.00% return.


PEN

YTD

18.19%

1M

1.20%

6M

18.01%

1Y

37.91%

5Y*

10.16%

10Y*

N/A

MEDP

YTD

-8.00%

1M

3.17%

6M

-1.60%

1Y

-22.28%

5Y*

28.67%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PEN vs. MEDP — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PEN
The Risk-Adjusted Performance Rank of PEN is 7979
Overall Rank
The Sharpe Ratio Rank of PEN is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of PEN is 7878
Sortino Ratio Rank
The Omega Ratio Rank of PEN is 7373
Omega Ratio Rank
The Calmar Ratio Rank of PEN is 7676
Calmar Ratio Rank
The Martin Ratio Rank of PEN is 8585
Martin Ratio Rank

MEDP
The Risk-Adjusted Performance Rank of MEDP is 2121
Overall Rank
The Sharpe Ratio Rank of MEDP is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of MEDP is 2222
Sortino Ratio Rank
The Omega Ratio Rank of MEDP is 2121
Omega Ratio Rank
The Calmar Ratio Rank of MEDP is 1313
Calmar Ratio Rank
The Martin Ratio Rank of MEDP is 2727
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PEN vs. MEDP - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Penumbra, Inc. (PEN) and Medpace Holdings, Inc. (MEDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current PEN Sharpe Ratio is 1.00, which is higher than the MEDP Sharpe Ratio of -0.51. The chart below compares the historical Sharpe Ratios of PEN and MEDP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

PEN vs. MEDP - Dividend Comparison

Neither PEN nor MEDP has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

PEN vs. MEDP - Drawdown Comparison

The maximum PEN drawdown since its inception was -62.64%, which is greater than MEDP's maximum drawdown of -42.87%. Use the drawdown chart below to compare losses from any high point for PEN and MEDP. For additional features, visit the drawdowns tool.


Loading data...

Volatility

PEN vs. MEDP - Volatility Comparison

The current volatility for Penumbra, Inc. (PEN) is 10.58%, while Medpace Holdings, Inc. (MEDP) has a volatility of 13.42%. This indicates that PEN experiences smaller price fluctuations and is considered to be less risky than MEDP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

PEN vs. MEDP - Financials Comparison

This section allows you to compare key financial metrics between Penumbra, Inc. and Medpace Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M600.00M20212022202320242025
324.14M
558.57M
(PEN) Total Revenue
(MEDP) Total Revenue
Values in USD except per share items

PEN vs. MEDP - Profitability Comparison

The chart below illustrates the profitability comparison between Penumbra, Inc. and Medpace Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%20212022202320242025
66.6%
31.9%
(PEN) Gross Margin
(MEDP) Gross Margin
PEN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Penumbra, Inc. reported a gross profit of 215.88M and revenue of 324.14M. Therefore, the gross margin over that period was 66.6%.

MEDP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Medpace Holdings, Inc. reported a gross profit of 178.35M and revenue of 558.57M. Therefore, the gross margin over that period was 31.9%.

PEN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Penumbra, Inc. reported an operating income of 40.35M and revenue of 324.14M, resulting in an operating margin of 12.5%.

MEDP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Medpace Holdings, Inc. reported an operating income of 113.52M and revenue of 558.57M, resulting in an operating margin of 20.3%.

PEN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Penumbra, Inc. reported a net income of 39.22M and revenue of 324.14M, resulting in a net margin of 12.1%.

MEDP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Medpace Holdings, Inc. reported a net income of 114.60M and revenue of 558.57M, resulting in a net margin of 20.5%.